SpectraCure AB (2OK) Stock Statistics & Valuation Metrics

SpectraCure AB has a market cap or net worth of €15.88M. The enterprise value is €234.07M.

SpectraCure AB has 97,131,610 shares outstanding. The number of shares has decreased by -2.65% in one year.

SpectraCure AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of SpectraCure AB is -18.82. SpectraCure AB’s PEG ratio is 0.98.

In the last 12 months, SpectraCure AB had revenue of 318.00K and earned -20.44M in profits. Earnings per share was -0.21.

In the last 12 months, operating cash flow was -21.82M and capital expenditures -15.28M, giving a free cash flow of -37.10M billion.

SpectraCure AB pays an annual dividend of ―, resulting in a dividend yield of ―

SpectraCure AB upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.

SpectraCure AB as a current ratio of 5.55, with Debt / Equity ratio of 4.81%

In the past 12 months, SpectraCure AB has paid -21.00K in taxes.

SpectraCure AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

SpectraCure AB has €18.27M in cash and marketable securities with kr5.14M in debt, giving a net cash position of -€13.13M billion.

Gross margin is 163.93%, with operating margin of -6714.15%, and net profit margin of -6427.99%.

The average price target for SpectraCure AB is ―, which is 11.43% higher than the current price. The consensus rating is ―